Therefore, low levels of IL-2 at baseline may result in the preferential expansion of long-lived memory CD4 + T cells but not CD8 + cytotoxic T-cell populations, thus potentially having an impact on anti-tumor activity and OS. This evidence concerns the gene CD8A and neoplasm.